company

University of Minnesota

as of 2026-07-01
Monitor thisAsk about this
at a glance
25 trials sponsored · 44 assets in the graph
Synthesized from structured facts only — each point cited above.

Financials

SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).

Pipeline

44 assets
OlanzapineQuetiapineRisperidoneActive TDCSBlood Pressure and Heart RateBody mass indexBrainHQ Computerized Cognitive Training - Visual Perception Training ParadigmBupropion HClCognitive Behavioral Social Skills TrainingCognitive RemediationCognitive and Social Cognitive TrainingCommercially available computerized trainingComprehensive Medication ManagementComputerized Cognitive TrainingComputerized plasticity-based adaptive cognitive trainingCoordinated Specialty Care for First Episode PsychosisD-serine solutionEarly Psychosis Coordinated Specialty CareGeneral Cognitive ExercisesGlucose and lipidsGlycosylated Hemoglobin A1cInformationMagnetic Resonance ImagingNicotine lozengeNicotine patchOlder participantsPersonalized Real-Time Intervention for Motivational Enhancement (PRIME) AppSprint Interval Training (SIT)Structured Cognitive Training & PRIMESugar PillTAUTAU + MIndfulness practiceTDCSTargeted cognitive trainingTherapyTranscranial Random Noise StimulationTranscranial alternating current stimulationVareniclineWaist and Hip circumferenceYounger participantsd-cycloserinemodafiniltranscranial direct current stimulationtranscranial direct current stimulation (tDCS)

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Olanzapine
small molecule
drug
Quetiapine
small molecule
drug
Risperidone
small molecule
drug
Active TDCS
OTHER
drug
Blood Pressure and Heart Rate
DEVICE
drug
Body mass index
DEVICE
drug
BrainHQ Computerized Cognitive Training - Visual Perception Training Paradigm
DEVICE
drug
Bupropion HCl
small molecule
drug